4.alpha.-Hydroxy-6-oxo-2.beta.-
arylmethoxy-methyl-3.alpha.-tetrahydropyranacetic acid .gamma.-lactones
    1.
    发明授权
    4.alpha.-Hydroxy-6-oxo-2.beta.- arylmethoxy-methyl-3.alpha.-tetrahydropyranacetic acid .gamma.-lactones 失效
    4 {60-羟基-6-氧代-2 {62-芳基甲氧基 - 甲基-3 {60-四氢吡喃乙酸{65-内酯

    公开(公告)号:US4094884A

    公开(公告)日:1978-06-13

    申请号:US784173

    申请日:1977-04-04

    申请人: Robert C. Kelly

    发明人: Robert C. Kelly

    摘要: The present specification provides novel intermediates and novel processes for the synthesis of Thromboxane B.sub.2 (11a-homo-11a-oxa-PGF.sub.2.alpha.), its 15-epimer, and various carboxyl derivatives thereof. In particular, there are disclosed various bicyclic tetrahydrofuran-containing lactones useful in the above processes, and corresponding acyclic lactones.

    摘要翻译: 本说明书提供了用于合成血栓烷B2(11a-homa-11a-oxa-PGF2α),其15-差向异构体及其各种羧基衍生物的新型中间体和新方法。 特别地,公开了可用于上述方法的各种双环四氢呋喃内酯,以及相应的无环内酯。

    5-Iodo-6-oxo-3-(2'-arylmethoxy-1'-hydroxyethyl)-4-hydroxy-hexanoic acid,
.gamma.-lactone dialkyl acetals
    3.
    发明授权
    5-Iodo-6-oxo-3-(2'-arylmethoxy-1'-hydroxyethyl)-4-hydroxy-hexanoic acid, .gamma.-lactone dialkyl acetals 失效
    (2- {40-芳基甲氧基-1 {40-羟乙基)-4-羟基 - 己酸,{65-内酯二烷基缩醛

    公开(公告)号:US4094883A

    公开(公告)日:1978-06-13

    申请号:US784177

    申请日:1977-04-04

    申请人: Robert C. Kelly

    发明人: Robert C. Kelly

    摘要: The present specification provides novel intermediates and novel processes for the synthesis of Thromboxane B.sub.2 (11a-homo-11a-oxa-PGF.sub.2.alpha.), its 15-epimer, and various carboxy derivatives thereof. In particular, there are disclosed various bicyclic tetrahydrofuran-containing lactones useful in the above processes, and corresponding acyclic lactones.

    摘要翻译: 本说明书提供了用于合成血栓烷B2(11a-homo-11a-oxa-PGF2α),其15-差向异构体及其各种羧基衍生物的新型中间体和新方法。 特别地,公开了可用于上述方法的各种双环四氢呋喃内酯,以及相应的无环内酯。

    4,5-Didehydro-6-hydroxy-2.beta.-aryl
methoxymethyl-3.alpha.-tetrahydropyranacetic acid.epsilon.-lactones
    4.
    发明授权
    4,5-Didehydro-6-hydroxy-2.beta.-aryl methoxymethyl-3.alpha.-tetrahydropyranacetic acid.epsilon.-lactones 失效
    4,5-二脱氢-6-羟基-2 {62-芳基甲氧基甲基-3 {60-四氢吡喃乙酸{68-内酯

    公开(公告)号:US4094882A

    公开(公告)日:1978-06-13

    申请号:US784176

    申请日:1977-04-04

    申请人: Robert C. Kelly

    发明人: Robert C. Kelly

    摘要: The present specification provides novel intermediates and novel processes for the synthesis of Thromboxane B.sub.2 (11a-homo-11a-oxa-PGF.sub.2.alpha.), its 15-epimer, and various carboxyl derivatives thereof. In particular, there are disclosed various bicyclic tetrahydrofuran-containing lactones useful in the above processes, and corresponding acyclic lactones.

    摘要翻译: 本说明书提供了用于合成血栓烷B2(11a-homa-11a-oxa-PGF2α),其15-差向异构体及其各种羧基衍生物的新型中间体和新方法。 特别地,公开了可用于上述方法的各种双环四氢呋喃内酯,以及相应的无环内酯。

    Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
    8.
    发明授权
    Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate 有权
    制备(3R,3aS,6aR) - 六氢呋喃并[2,3-b]呋喃-3-基(1S,2R)-3 [[(4-氨基苯基)磺酰基](异丁基)氨基] -1- 苄基-2-羟丙基氨基甲酸酯

    公开(公告)号:US07772411B2

    公开(公告)日:2010-08-10

    申请号:US10596732

    申请日:2004-12-23

    IPC分类号: C07D493/04

    CPC分类号: C07D493/02 C07D493/04

    摘要: The present invention relates to a process for the preparation of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate as well as intermediates for use in said process. More in particular the invention relates to processes for the preparation of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate which make use of 4-amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-(isobutyl)benzene sulfonamide intermediate, and to processes amenable to industrial scaling up. (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate is particularly useful as HIV protease inhibitors.

    摘要翻译: 本发明涉及制备(3R,3aS,6aR) - 六氢呋喃并[2,3-b]呋喃-3-基(1S,2R)-3 - [[(4-氨基苯基)磺酰基] 异丁基)氨基] -1-苄基-2-羟基丙基氨基甲酸酯以及用于所述方法的中间体。 更具体地,本发明涉及制备(3R,3aS,6aR) - 六氢呋喃并[2,3-b]呋喃-3-基(1S,2R)-3 - [[(4-氨基苯基)磺酰基] 使用4-氨基-N - ((2R,3S)-3-氨基-2-羟基-4-苯基丁基)-N-(异丁基)苯磺酰胺的(异丁基)氨基] -1-苄基-2-羟基丙基氨基甲酸叔丁酯 中间和适用于工业规模化的流程。 (3R,3aS,6aR) - 六氢呋喃并[2,3-b]呋喃-3-基(1S,2R)-3 - [[(4-氨基苯基)磺酰基](异丁基)氨基] -1-苄基-2- 羟丙基氨基甲酸酯特别可用作HIV蛋白酶抑制剂。

    Bicyclic tetrahydrofuran lactone derivatives and process for the preparation thereof
    9.
    发明申请
    Bicyclic tetrahydrofuran lactone derivatives and process for the preparation thereof 失效
    双环四氢呋喃内酯衍生物及其制备方法

    公开(公告)号:US20070010679A1

    公开(公告)日:2007-01-11

    申请号:US11303125

    申请日:2005-12-15

    IPC分类号: C07D493/02

    CPC分类号: C07D493/02

    摘要: The present invention relates to bicyclic tetrahydrofuran lactone derivatives of Formula (1) and a preparation method thereof, and particularly it relates to a process of preparing compounds of Formula (1) by performing an intramolecular cyclization of tetrahydrofuran-allenic acid derivatives in the presence of a phenyl halide, a palladium catalyst and a base: wherein n is 1 or 2, and R is phenyl optionally substituted with C1-C6 alkyl, C1-C6 alkoxy, hydroxyl or C1-C6 hydroxyalkyl group.

    摘要翻译: 本发明涉及式(1)的双环四氢呋喃内酯衍生物及其制备方法,特别涉及通过在四氢呋喃 - 异丙酸衍生物的存在下进行分子内环化制备式(1)化合物的方法, 苯基卤化物,钯催化剂和碱:其中n为1或2,R为任选被C 1 -C 6烷基取代的苯基,C 1 -C 6烷基, C 1 -C 6烷氧基,羟基或C 1 -C 6羟烷基。

    4,5-Didehydro-6-methoxy-2-arylmethoxymethyl-4.alpha.-tetrahydropyranacet
ic acid alkyl esters
    10.
    发明授权
    4,5-Didehydro-6-methoxy-2-arylmethoxymethyl-4.alpha.-tetrahydropyranacet ic acid alkyl esters 失效
    4,5-二脱氢-6-甲氧基-2-芳基甲氧基甲基-4 {60-四氢吡喃乙酸烷基酯

    公开(公告)号:US4100178A

    公开(公告)日:1978-07-11

    申请号:US784178

    申请日:1977-04-04

    申请人: Robert C. Kelly

    发明人: Robert C. Kelly

    摘要: The present specification provides novel intermediates and novel processes for the synthesis of Thromboxane B.sub.2 11a-homo-11a-oxa-PGF.sub.2.alpha.), its 15-epimer, and various carboxyl derivatives thereof. In particular, there are disclosed various bicyclic tetrahydrofuran-containing lactones useful in the above processes, and corresponding acyclic lactones.

    摘要翻译: 本说明书提供了用于合成血栓烷B211a-homa-11a-oxa-PGF2α),其15-差向异构体及其各种羧基衍生物的新型中间体和新方法。 特别地,公开了可用于上述方法的各种双环四氢呋喃内酯,以及相应的无环内酯。